PTC Historical Balance Sheet

PTCT Stock

USD 56.27 0.76 1.33%

Trend analysis of PTC Therapeutics balance sheet accounts such as Accounts Payable of 10.5 M, Cash of 818.7 M, Other Assets of 40.3 M or Long Term Debt of 2.2 B provides information on PTC Therapeutics' total assets, liabilities, and equity, which is the actual value of PTC Therapeutics to its prevalent stockholders. By breaking down trends over time using PTC Therapeutics balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining PTC Therapeutics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether PTC Therapeutics is a good buy for the upcoming year.

PTC Therapeutics Inventory

14.48 Million

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PTC Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

For more information on how to buy PTC Stock please use our How to Invest in PTC Therapeutics guide.

About PTC Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of PTC Therapeutics at a specified time, usually calculated after every quarter, six months, or one year. PTC Therapeutics Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of PTC Therapeutics and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which PTC currently owns. An asset can also be divided into two categories, current and non-current.

PTC Therapeutics Balance Sheet Chart

At this time, PTC Therapeutics' Short and Long Term Debt Total is comparatively stable compared to the past year. Non Current Assets Total is likely to gain to about 472.3 M in 2025, whereas Other Liabilities is likely to drop slightly above 263.2 M in 2025.

Total Assets Other Current Liab Total Current Liabilities Other Liab Retained Earnings Total Equity

Add Fundamental

Total Assets

Total assets refers to the total amount of PTC Therapeutics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in PTC Therapeutics books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on PTC Therapeutics balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of PTC Therapeutics are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Retained Earnings Total Equity

The portion of total equity that consists of earnings retained by the company, reinvested in its core business or used to pay debt.

Most accounts from PTC Therapeutics' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into PTC Therapeutics current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PTC Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

For more information on how to buy PTC Stock please use our How to Invest in PTC Therapeutics guide.At this time, PTC Therapeutics' Short and Long Term Debt Total is comparatively stable compared to the past year. Non Current Assets Total is likely to gain to about 472.3 M in 2025, whereas Other Liabilities is likely to drop slightly above 263.2 M in 2025.

	2022	2023	2024	2025 (projected)
Other Current Liabilities	348.2M	385.9M	526.8M	553.1M
Total Assets	1.7B	1.9B	1.7B	952.2M

Other Current Liab Total Assets

PTC Therapeutics balance sheet Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Accounts Payable	Cash	Other Assets	Long Term Debt	Short Term Investments	Other Current Assets	Total Liab	Property Plant Equipment	Short Long Term Debt Total	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Stockholder Equity
Total Assets		0.66	0.8	-0.2	0.83	0.72	0.69	0.88	0.49	0.7	0.33	0.81	0.72	0.59	0.83	0.29	0.28	-0.74	0.91	0.61	0.8	0.78	0.92	0.95	0.79	0.28
Other Current Liab	0.66		0.88	-0.74	0.3	0.43	0.73	0.71	0.92	0.29	0.6	0.92	0.66	0.54	0.68	-0.17	0.2	-0.94	0.47	0.13	0.83	0.91	0.67	0.74	0.95	0.22
Total Current Liabilities	0.8	0.88		-0.71	0.54	0.57	0.86	0.84	0.87	0.43	0.34	0.99	0.91	0.67	0.83	0.28	0.26	-0.98	0.66	0.54	0.86	0.97	0.78	0.88	0.96	0.27
Total Stockholder Equity	-0.2	-0.74	-0.71		0.11	-0.13	-0.49	-0.39	-0.88	0.11	-0.38	-0.71	-0.61	-0.47	-0.52	0.04	-0.26	0.77	-0.01	-0.05	-0.48	-0.71	-0.25	-0.39	-0.72	-0.12
Other Liab	0.83	0.3	0.54	0.11		0.61	0.47	0.8	0.14	0.83	-0.11	0.54	0.6	0.22	0.56	0.58	0.0	-0.41	0.87	0.79	0.64	0.45	0.67	0.69	0.5	0.21
Accounts Payable	0.72	0.43	0.57	-0.13	0.61		0.55	0.7	0.25	0.5	0.07	0.58	0.66	0.21	0.68	0.37	-0.08	-0.57	0.7	0.62	0.54	0.63	0.77	0.76	0.54	0.31
Cash	0.69	0.73	0.86	-0.49	0.47	0.55		0.65	0.73	0.43	0.07	0.81	0.81	0.47	0.57	0.34	-0.08	-0.82	0.57	0.53	0.82	0.8	0.76	0.78	0.76	0.33
Other Assets	0.88	0.71	0.84	-0.39	0.8	0.7	0.65		0.59	0.79	0.28	0.87	0.81	0.48	0.84	0.34	0.18	-0.79	0.76	0.65	0.89	0.78	0.77	0.84	0.85	0.23
Long Term Debt	0.49	0.92	0.87	-0.88	0.14	0.25	0.73	0.59		0.18	0.51	0.88	0.66	0.61	0.6	-0.11	0.27	-0.92	0.26	0.1	0.78	0.85	0.55	0.63	0.89	0.19
Short Term Investments	0.7	0.29	0.43	0.11	0.83	0.5	0.43	0.79	0.18		0.01	0.46	0.45	0.21	0.47	0.35	-0.03	-0.35	0.57	0.59	0.73	0.3	0.58	0.57	0.43	0.18
Other Current Assets	0.33	0.6	0.34	-0.38	-0.11	0.07	0.07	0.28	0.51	0.01		0.43	0.01	0.64	0.48	-0.69	0.68	-0.46	0.14	-0.41	0.32	0.45	0.32	0.37	0.51	0.1
Total Liab	0.81	0.92	0.99	-0.71	0.54	0.58	0.81	0.87	0.88	0.46	0.43		0.87	0.65	0.84	0.17	0.28	-0.98	0.66	0.47	0.89	0.97	0.78	0.88	0.99	0.27
Property Plant Equipment	0.72	0.66	0.91	-0.61	0.6	0.66	0.81	0.81	0.66	0.45	0.01	0.87		0.5	0.81	0.6	0.1	-0.85	0.66	0.79	0.73	0.85	0.69	0.79	0.81	0.22
Short Long Term Debt Total	0.59	0.54	0.67	-0.47	0.22	0.21	0.47	0.48	0.61	0.21	0.64	0.65	0.5		0.75	0.0	0.84	-0.66	0.44	0.23	0.49	0.66	0.56	0.65	0.64	0.2
Property Plant And Equipment Net	0.83	0.68	0.83	-0.52	0.56	0.68	0.57	0.84	0.6	0.47	0.48	0.84	0.81	0.75		0.27	0.53	-0.82	0.71	0.57	0.66	0.84	0.76	0.87	0.83	0.22
Current Deferred Revenue	0.29	-0.17	0.28	0.04	0.58	0.37	0.34	0.34	-0.11	0.35	-0.69	0.17	0.6	0.0	0.27		-0.2	-0.1	0.43	0.92	0.14	0.14	0.19	0.26	0.07	0.09
Net Debt	0.28	0.2	0.26	-0.26	0.0	-0.08	-0.08	0.18	0.27	-0.03	0.68	0.28	0.1	0.84	0.53	-0.2		-0.27	0.19	-0.05	0.08	0.29	0.18	0.27	0.3	0.01
Retained Earnings	-0.74	-0.94	-0.98	0.77	-0.41	-0.57	-0.82	-0.79	-0.92	-0.35	-0.46	-0.98	-0.85	-0.66	-0.82	-0.1	-0.27		-0.56	-0.38	-0.85	-0.98	-0.78	-0.85	-0.97	-0.26
Non Current Assets Total	0.91	0.47	0.66	-0.01	0.87	0.7	0.57	0.76	0.26	0.57	0.14	0.66	0.66	0.44	0.71	0.43	0.19	-0.56		0.7	0.59	0.67	0.78	0.82	0.63	0.26
Non Currrent Assets Other	0.61	0.13	0.54	-0.05	0.79	0.62	0.53	0.65	0.1	0.59	-0.41	0.47	0.79	0.23	0.57	0.92	-0.05	-0.38	0.7		0.44	0.43	0.5	0.56	0.38	0.15
Cash And Short Term Investments	0.8	0.83	0.86	-0.48	0.64	0.54	0.82	0.89	0.78	0.73	0.32	0.89	0.73	0.49	0.66	0.14	0.08	-0.85	0.59	0.44		0.79	0.78	0.8	0.88	0.24
Net Receivables	0.78	0.91	0.97	-0.71	0.45	0.63	0.8	0.78	0.85	0.3	0.45	0.97	0.85	0.66	0.84	0.14	0.29	-0.98	0.67	0.43	0.79		0.8	0.88	0.96	0.28
Common Stock Total Equity	0.92	0.67	0.78	-0.25	0.67	0.77	0.76	0.77	0.55	0.58	0.32	0.78	0.69	0.56	0.76	0.19	0.18	-0.78	0.78	0.5	0.78	0.8		0.93	0.75	0.21
Common Stock Shares Outstanding	0.95	0.74	0.88	-0.39	0.69	0.76	0.78	0.84	0.63	0.57	0.37	0.88	0.79	0.65	0.87	0.26	0.27	-0.85	0.82	0.56	0.8	0.88	0.93		0.85	0.44
Non Current Liabilities Total	0.79	0.95	0.96	-0.72	0.5	0.54	0.76	0.85	0.89	0.43	0.51	0.99	0.81	0.64	0.83	0.07	0.3	-0.97	0.63	0.38	0.88	0.96	0.75	0.85		0.27
Other Stockholder Equity	0.28	0.22	0.27	-0.12	0.21	0.31	0.33	0.23	0.19	0.18	0.1	0.27	0.22	0.2	0.22	0.09	0.01	-0.26	0.26	0.15	0.24	0.28	0.21	0.44	0.27

Click cells to compare fundamentals

PTC Therapeutics Account Relationship Matchups

PTC Therapeutics balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	2.2B	1.9B	1.7B	1.9B	1.7B	952.2M
Other Current Liab	232.7M	60.8M	348.2M	385.9M	526.8M	553.1M
Total Current Liabilities	277.3M	509.3M	406.2M	603.1M	581.0M	610.0M
Total Stockholder Equity	482.0M	1.4M	(347.1M)	(818.6M)	(1.1B)	(1.0B)
Other Liab	490.7M	1.0B	1.1B	269.5M	309.9M	263.2M
Accounts Payable	18.7M	23.0M	27.3M	6.0M	17.3M	10.5M
Cash	208.8M	773.4M	410.7M	594.0M	779.7M	818.7M
Other Assets	16.4M	60.6M	46.5M	33.4M	38.4M	40.3M
Long Term Debt	309.1M	281.9M	571.7M	1.9B	2.1B	2.2B
Short Term Investments	894.8M	583.7M	130.9M	282.7M	360.0M	289.8M
Other Current Assets	78.9M	(126.3M)	105.7M	150.3M	44.1M	46.3M
Total Liab	1.7B	1.9B	2.1B	2.7B	2.8B	2.9B
Property Plant Equipment	21.5M	33.8M	130.0M	72.6M	83.5M	87.7M
Short Long Term Debt Total	420.4M	441.7M	703.6M	2.2B	389.3M	439.9M
Property Plant And Equipment Net	118.2M	130.0M	175.0M	179.0M	117.7M	63.9M
Current Deferred Revenue	4.2M	265.8M	1.4M	801K	5.5M	5.2M
Net Debt	211.6M	(341.9M)	292.9M	1.6B	(390.4M)	(370.9M)
Retained Earnings	(1.6B)	(2.1B)	(2.7B)	(3.3B)	(3.6B)	(3.5B)
Non Current Assets Total	976.5M	1.2B	1.0B	677.1M	339.5M	472.3M
Non Currrent Assets Other	60.6M	227.5M	48.6M	36.2M	20.7M	34.0M
Cash And Short Term Investments	1.1B	773.4M	410.7M	876.7M	1.1B	1.2B
Net Receivables	69.9M	110.5M	155.6M	161.0M	158.6M	166.5M
Common Stock Total Equity	62K	70K	71K	72K	82.8K	45.3K
Common Stock Shares Outstanding	66.0M	70.5M	71.7M	74.8M	76.8M	52.2M
Liabilities And Stockholders Equity	2.2B	1.9B	1.7B	1.9B	1.7B	1.1B
Non Current Liabilities Total	1.4B	1.2B	1.6B	2.1B	2.2B	2.3B
Other Stockholder Equity	2.2B	2.1B	2.3B	2.5B	2.6B	2.7B
Property Plant And Equipment Gross	118.2M	157.2M	212.4M	230.3M	151.0M	75.7M
Total Current Assets	1.2B	773.4M	693.8M	1.2B	1.4B	1.4B
Accumulated Other Comprehensive Income	(61.0M)	(24.3M)	4.8M	(1.3M)	(25.9M)	(24.6M)
Short Term Debt	17.5M	159.8M	24.7M	210.3M	26.7M	25.4M
Common Stock	70K	71K	72K	75K	77K	50.8K
Net Tangible Assets	(198.5M)	(315.7M)	(805.7M)	(1.1B)	(1.0B)	(970.7M)
Retained Earnings Total Equity	(1.2B)	(1.6B)	(2.1B)	(2.7B)	(2.4B)	(2.3B)
Capital Surpluse	1.8B	2.2B	2.1B	2.3B	2.7B	1.6B
Inventory	18.7M	15.9M	21.8M	30.6M	23.2M	14.5M
Deferred Long Term Liab	130.9M	136.7M	137.1M	102.8M	118.3M	70.3M
Non Current Liabilities Other	1.0B	1.0B	971.9M	141K	21.4M	20.4M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for PTC Stock Analysis

When running PTC Therapeutics' price analysis, check to measure PTC Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PTC Therapeutics is operating at the current time. Most of PTC Therapeutics' value examination focuses on studying past and present price action to predict the probability of PTC Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PTC Therapeutics' price. Additionally, you may evaluate how the addition of PTC Therapeutics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

PTC Historical Balance Sheet

PTC Therapeutics Inventory

14.48 Million

About PTC Balance Sheet Analysis

PTC Therapeutics Balance Sheet Chart

Total Assets

Total Current Liabilities

Retained Earnings Total Equity

PTC Therapeutics balance sheet Correlations

PTC Therapeutics Account Relationship Matchups

High Positive Relationship

High Negative Relationship

PTC Therapeutics balance sheet Accounts

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for PTC Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Liab	+ 0.99	Total Current Liabilities
Non Current Liabilities Total	+ 0.99	Total Liab
Net Receivables	+ 0.97	Total Current Liabilities
Net Receivables	+ 0.97	Total Liab
Non Current Liabilities Total	+ 0.96	Total Current Liabilities
Non Current Liabilities Total	+ 0.96	Net Receivables

Net Receivables	- 0.98	Retained Earnings
Retained Earnings	- 0.98	Total Liab
Retained Earnings	- 0.98	Total Current Liabilities
Non Current Liabilities Total	- 0.97	Retained Earnings
Retained Earnings	- 0.94	Other Current Liab
Retained Earnings	- 0.92	Long Term Debt